← Leaderboards
Corinne Beinat
Stanford University
$2,431,678
Attributed
$2,431,678
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $905.5K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,431,678 · 4
By mechanism
R21$1,063,269 · 2
R37$938,536 · 1
R01$429,873 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Craig S Levin$29,139,614
- Donna M Peehl$4,923,077
- Frederick T Chin$4,587,637
- Garry P Nolan$53,568,535
- Robert Michael Angelo$7,860,542
Others in their field
Other Emerging Leaders on “Uptake”
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Paula Gonzalez-Maya · Fundacion Inciensa$17,061,460
- Emmanuel Aja Oga · Research Triangle Institute$16,442,002
- Sonia Minikel Vallabh · Broad Institute, Inc.$14,507,691
- Rainer Lohmann · University Of Rhode Island$14,400,221
Research focus
UptakePositron-Emission TomographyRadiotracerSpecificityCellsBiodistributionMalignant NeoplasmsImagePropertyBindingRadiolabeledClinical ResearchClinical TranslationClinically RelevantVisualizationMediatingDoseTranslationsCell Culture TechniquesIn VivoKnock-DownSmall Interfering RnaBlood - Brain Barrier AnatomyPrimary Brain Neoplasms
Grant awards (8)
Novel MUC1 Theranostic Peptides for Imaging and Treatment of Triple-Negative Breast Cancer$475,676
R37 · FY2025 · CA · contact PI
Novel applications and translation of [18F]hGTS13, a system xc- specific radiopharmaceutical$429,873
R01 · FY2025 · CA · contact PI
Novel MUC1 Theranostic Peptides for Imaging and Treatment of Triple-Negative Breast Cancer$462,860
R37 · FY2024 · CA · contact PI
Molecular Imaging of Pyruvate Kinase M2$196,909
R21 · FY2024 · EB · contact PI
Molecular Imaging of Pyruvate Kinase M2$196,873
R21 · FY2023 · EB · contact PI
Molecular Imaging of Pyruvate Kinase M2$236,100
R21 · FY2022 · EB · contact PI
Development of A Novel Imaging Strategy for Evaluation of CAR T-Cell Therapy in Glioblastoma$197,036
R21 · FY2022 · NS · contact PI
Development of A Novel Imaging Strategy for Evaluation of CAR T-Cell Therapy in Glioblastoma$236,351
R21 · FY2021 · NS · contact PI